Retrospective and prospective multi-center study Indication: Fertility-sparing surgery for patients with borderline ovarian tumor and fertility Objectives: * Description of the characteristics of the patients of less than 45 years having a fertility-sparing surgery for borderline ovarian tumors, the modalities of care and their fertility. * Validation of a nomogram as an information medium to the patients concerned on their chance of alive birth according to their personal characteristics Origin and nature of the specific data: * Extraction from the database " Tumeurs Malignes Rares de l'Ovaire " (TMRO) * Collection of retrospective further informations in the participating centers * Data collection from the patients (questionnaires) The data will be identified by the TMRO number allocated to every participant of the TMRO study . Data traffic : TMRO database extraction for the patients with BOT and corresponding to the inclusion criteria, supplied by Arcagy-Gineco. The database will be managed by the coordination team in an anonymous way by means of the patient identifiers of the TMRO base. Enrichment of the base by the anonymous questionnaires filled by the patients and the complementary data transmissions of the centers on anonymised files.
Study Type
OBSERVATIONAL
Enrollment
176
Institut Bergonié
Bordeaux, France
Centre Jean PERRIN
Clermont-Ferrand, France
Centre Leon Berard
Lyon, France
Institut Paoli CALMETTES
Marseille, France
Institut Curie, Paris
Paris, France
Hôpital Européen Goerges POMPIDOU
Paris, France
Goupe Hospitalier Diaconesses Croix Saint-Simon
Paris, France
Centre Hospitalier Intercommunal Poissy - Saint-Germain
Poissy, France
Institut Curie - Saint-Cloud
Saint-Cloud, France
IUCT Oncopole - Institut Claudius Regaud
Toulouse, France
...and 1 more locations
Description of the characteristics of the patients of less than 45 years having a fertility-sparing surgery for borderline ovarian tumors
Univariate and multivariate analysis on patients modalities of care and fertility , through medical history and questionnaires (study based on patients who were included in the previous study "Observatoire Sur Les Tumeurs Malignes Rares de l'Ovaire" (TMRO french network)
Time frame: December 2018
Validation of a nomogram as an information medium to the patients concerned on their chance of alive birth according to their personal characteristics
Test of a published fertility prognostic tool in this population. Estimation of the precision of the estimation of alive birth in our cohort will be done by determining the difference between predicted live birth and observed rate of live birth.
Time frame: December 2018
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.